SCHEMBL3685134

SCHEMBL3685134

Cc1ccc(S(=O)(=O)n2cc(Br)c(C)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 3/20 0.50
LMNA P02545 3/20 0.50
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
PIK3CD O00329 1/20 0.46
PIK3CA P42336 1/20 0.46
PIK3CB P42338 1/20 0.46
PIK3CG P48736 1/20 0.46
TSHR P16473 1/20 0.45
PKM P14618 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
CA12 O43570 1/20 0.41
CA3 P07451 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5254330 0.87 MEN1 (0.48) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL18976161 0.84 MEN1 (0.51) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL18976162 0.84 MEN1 (0.67) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL18976160 0.80 KMT2A (0.48) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL5055447 0.80 MEN1 (0.54) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL3108566 0.79 MAPT (0.60) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL13953681 0.79 MEN1 (0.47) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL5062979 0.79 KMT2A (0.52) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL21724349 0.75 ALDH1A1 (0.50) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL422433 0.73 GRM4 (0.48) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2173354-A1 QUINOXALINE DERIVATIVES AS PI3 KINASE INHIBITORS GlaxoSmithKline LLC (US) 2010-04-14 EP disclosed
WO-2009021083-A1 QUINOXALINE DERIVATIVES AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-02-12 WO disclosed